$CVM FDA’s Approval of Keytruda for PD-L1 Positi
Post# of 38690
(Total Views: 42)
Posted On: 08/06/2025 7:37:16 AM
$CVM FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients
https://finance.yahoo.com/news/fda-approval-k...00220.html
https://finance.yahoo.com/news/fda-approval-k...00220.html
(0)
(0)